Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

HIV prevalence and incidence among sexually active females in two districts of South Africa to determine microbicide trial feasibility.

Nel A, Louw C, Hellstrom E, Braunstein SL, Treadwell I, Marais M, de Villiers M, Hugo J, Paschke I, Andersen C, van de Wijgert J.

PLoS One. 2011;6(8):e21528. doi: 10.1371/journal.pone.0021528. Epub 2011 Aug 10.

2.

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath MJ, Robertson M, Corey L, Kublin JG; HVTN 503/Phambili study team.

Lancet Infect Dis. 2011 Jul;11(7):507-15. doi: 10.1016/S1473-3099(11)70098-6. Epub 2011 May 11. Erratum in: Lancet Infect Dis. 2011 Jul;11(7):495.

3.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team.

N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.

4.

Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.

Karim QA, Kharsany AB, Frohlich JA, Werner L, Mashego M, Mlotshwa M, Madlala BT, Ntombela F, Abdool Karim SS.

Int J Epidemiol. 2011 Aug;40(4):922-30. doi: 10.1093/ije/dyq176. Epub 2010 Nov 3.

5.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group.

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29;333(6042):524.

6.

A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008.

Rehle TM, Hallett TB, Shisana O, Pillay-van Wyk V, Zuma K, Carrara H, Jooste S.

PLoS One. 2010 Jun 14;5(6):e11094. doi: 10.1371/journal.pone.0011094.

7.

(ARV-) Free State? The moratorium's threat to patients' adherence and the development of drug-resistant HIV.

El-Khatib Z, Richter M.

S Afr Med J. 2009 Jun;99(6):412, 414. No abstract available.

PMID:
19739316
8.

The effect of educational attainment and other factors on HIV risk in South African women: results from antenatal surveillance, 2000-2005.

Johnson LF, Dorrington RE, Bradshaw D, du Plessis H, Makubalo L.

AIDS. 2009 Jul 31;23(12):1583-8. doi: 10.1097/QAD.0b013e32832d407e.

PMID:
19521233
9.

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P.

Lancet. 2008 Dec 6;372(9654):1977-87. doi: 10.1016/S0140-6736(08)61842-5.

PMID:
19059048
10.

Explaining continued high HIV prevalence in South Africa: socioeconomic factors, HIV incidence and sexual behaviour change among a rural cohort, 2001-2004.

Hargreaves JR, Bonell CP, Morison LA, Kim JC, Phetla G, Porter JD, Watts C, Pronyk PM.

AIDS. 2007 Nov;21 Suppl 7:S39-48.

PMID:
18040163
11.

The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study.

Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B; HPTN 055 Study Team.

J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):93-100.

PMID:
17984760
12.

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J; MIRA Team.

Lancet. 2007 Jul 21;370(9583):251-61.

13.

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO.

Lancet. 2007 Feb 24;369(9562):643-56.

PMID:
17321310
14.

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A.

PLoS Med. 2005 Nov;2(11):e298. Epub 2005 Oct 25. Erratum in: PLoS Med. 2006 May;3(5):e298.

Supplemental Content

Support Center